This research was completed on 6 February 2006
|Project Leader||Professor Richard A C Hughes MD FRCP FMedSci, Professor Adrian C Hayday PhD, Professor Kenneth J Smith PhD and Dr Norman A Gregson PhD|
|Location||Guy's, King's and St Thomas' School of Medicine, Department of Neuroimmunology and The Peter Gorer Department of Immunobiology, Guy's Hospital, London.|
|Grant awarded||26 October 2000|
|Start date||18 March 2002|
|End date||6 February 2006|
We do not provide medical advice. If you would like more information about a condition or would like to talk to someone about your health, contact NHS Choices or speak to your GP. Please see our useful links page for some links to health information, organisations we are working with and other useful organisations. We hope you will find these useful. We are not responsible for the content of any of these sites.
Guillain-Barré syndrome is the most common cause of acute neuromuscular paralysis, affecting 2000 patients each year in the United Kingdom, and leaving 20% of them dead or disabled. It is thought to be an 'autoimmune' disease, in which the body's defence mechanisms erroneously attack its own tissues in this case the peripheral nerve sheaths. These researchers will further investigate their original finding that a protein covering the nerve (peripheral myelin protein 22) is the target of this autoimmune attack. Such an improvement in our understanding of the cause of Guillain-Barré syndrome should then help us design better treatment for patients.